Concepedia

Hans Stange

HS

4

Publications

197

Citations

4

H-Index

2010

Active since

Affiliations

BioCrea (Germany)(Current)

Pfizer (United States)

Hans Stange is an author at BioCrea (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2010–2012

4

Publications

4

Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors

Michael S. Malamas, Yike Ni, James Erdei et al. · Journal of Medicinal Chemistry · 2011 · 72 citations · Full text

, , +15

Discovery of Imidazo[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors

Norbert Höfgen, Hans Stange, Rudolf Schindler et al. · Journal of Medicinal Chemistry · 2010 · 63 citations · Full text

, , +16

Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test

Barbara Langen, Rita Dost, Ute Egerland et al. · Psychopharmacology · 2011 · 36 citations

, , +3

Novel triazines as potent and selective phosphodiesterase 10A inhibitors

Michael S. Malamas, Hans Stange, Rudolf Schindler et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 26 citations · Full text

, , +6

Rows per page

1–4 of 4